The structure of an MDM2-Nutlin-3a complex solved by the use of a validated MDM2 surface-entropy reduction mutant (Q27685287)

1

0 references

Christiane Riedinger

2

0 references

Jane A Endicott

3

0 references

Martin E M Noble

Acta Crystallographica Section D: Biological Crystallography

4

0 references

publication date

August 2013

0 references

published in

0 references

volume

69

0 references

issue

Pt 8

0 references

page(s)

1358-66

0 references

cites work

Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Measures of residue density in protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Awakening guardian angels: drugging the p53 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

The protein as a variable in protein crystallization

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Rational protein crystallization by mutational surface engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

It's all in the crystals…

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Structure-based design of potent non-peptide MDM2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Coot: model-building tools for molecular graphics

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Control of apoptosis by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

The central valine concept provides an entry in a new class of non peptide inhibitors of the p53-MDM2 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Toward rational protein crystallization: A Web server for the design of crystallizable protein variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein-protein interaction: structure-activity studies leading to improved potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

The atomic structure of protein-protein recognition sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Phasercrystallographic software

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

The MDM2 gene amplification database

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

REFMAC5 for the refinement of macromolecular crystal structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Amplification of a gene encoding a p53-associated protein in human sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

High-density miniaturized thermal shift assays as a general strategy for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53?

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Structure-based design of novel inhibitors of the MDM2-p53 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Analysis of chemical shift changes reveals the binding modes of isoindolinone inhibitors of the MDM2-p53 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Inhibitors of MDM2 and MDMX: a structural perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft.

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Structure of free MDM2 N-terminal domain reveals conformational adjustments that accompany p53-binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

The p53 orchestra: Mdm2 and Mdmx set the tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Overexpression of the MDM2 oncogene in leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Patented inhibitors of p53-Mdm2 interaction (2006 - 2008).

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459

Overview of the CCP4 suite and current developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1107%2FS0907444913004459